PDP IV – Advancing the clinical development of placental malaria vaccines

This project is implemented under the PDP IV programme by the European Vaccine Initiative (EVI).

EVI's mission is to reduce the burden of poverty-related infectious diseases through the development of new, safe, effective, and affordable vaccines against diseases that disproportionately affect low- and middle-income countries (LMICs). Vulnerable populations, notably children and women of childbearing age, are the target groups of EVI's efforts.

Women with their babies
Good Health and Well-beingGender Equality

Project number

NL-KVK-27378529-PDP22DE02

Total budget

€ 17,247,700

Countries

Benin, Burkina Faso, Malawi, Mali

Project status

Implementation

Budget spent

47.50 %
47.50 % spent

Tied status

Untied
Startdate:
Enddate:

Project partners

European Vaccine Initiative, Netherlands Enterprise Agency

Sectors

Malaria control
Transactions
TypeProviderProvider ref.ReceiverReceiver ref.Value (€)DateValue date
Incoming Funds 17,247,700.00 16-12-2022 16-12-2022
Outgoing Commitment European Vaccine Initiative 17,247,700.00 16-12-2022 16-12-2022
Disbursement European Vaccine Initiative 1,638,531.50 22-12-2022 22-12-2022
Disbursement European Vaccine Initiative 1,638,531.50 18-07-2023 18-07-2023
Disbursement European Vaccine Initiative 1,638,531.50 22-01-2024 22-01-2024
Disbursement European Vaccine Initiative 1,638,531.50 16-07-2024 16-07-2024
Disbursement European Vaccine Initiative 1,638,531.50 11-02-2025 11-02-2025